Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested

Publisher： Karger

E-ISSN： 1662-6575|6|2|263-268

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.6, Iss.2, 2013-05, pp. : 263-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 11, 2015-11 ,pp. : 633-643

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 10, 2015-11 ,pp. : 818-822

John Wiley & Sons Inc

Access to resources Recommend Favorite

Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 18, 2015-09 ,pp. : 4560-4574

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer according to the Type of Epidermal Growth Factor Receptor Mutation

By  

Oncology, Vol. 87, Iss. 4, 2014-07 ,pp. : 215-223

Karger

Access to resources Recommend Favorite